The Hancock™ II valve has stood the test of time. First introduced in the 1980s, it has been tested, studied and earned the trust of cardiac surgeons around the world. After dozens of years, and improvements along the way, there are scores of reasons to use this valve with your patients.
The Hancock II and Hancock II Ultra™ are for patients who require replacement of their native or prosthetic aortic and/or mitral valves.
Published clinical experience demonstrates impressive long-term performance in all age groups for both the aortic and mitral valve.
Additional factors that may contribute to durability are the following:
T6 (sodium dodecyl sulfate) anti-calcification treatment is applied in order to mitigate the absorption of calcium in the leaflets
Next generation flexible polymer stent allows for absorption of stress produced during the cardiac cycle
Low pressure fixation process minimizes septal muscle shelf allowing for improved hemodynamics
Our innovative Cinch™ implant system further capitalizes on the valve’s flexible stent to facilitate valve implantation, particularly through a tight sinotubular space. It also:
Improves overall visualization
Has stent posts that deflect to allow for easier knot tying near the posts in aortic replacements
Helps prevent suture looping
Facilitates minimally invasive procedures
Protects tissue from inadvertent damage